In May 2017, the new regulation for in-vitro diagnostics (IVDR) came into force, which will apply from May 2022 and in particular provides for higher requirements for placing these products on the market. At the same time, the Corona crisis has shown the importance of efficient and innovative diagnostics.
Against this background, the Association of German Chambers of Industry and Commerce (DIHK) would like to use this company survey (approx. 5 minutes) to find out what effects and challenges you expect and what political measures you would support. The results of the survey should be used to identify problems in politics and administration and to provide arguments for an industry and medium-sized company-friendly implementation. The link to the online survey you here. Thanks for your support.